Data tells us that nuclear medicine has made extraordinary strides in curing prostate cancer, especially with the use of PSMA PET. But how are we reporting on PSMA, and how can this data be standardized globally? SPARC could be the answer! SPARC stands for "Standardized PSMA Reporting Criteria," and it's been initiated because of the widespread use and success of PSMA PET. These guidelines were developed by asking the end-users of PSMA PET reporting what they need and working backwards from there. So what went into this process, and what guidelines may we see going forward? On this episode of The JNM Podcast, host Ken Herrmann talks with Louise Emmett, MD, Anders Bjartell, MD, PhD, FEBU, Michael Morris, MD, and Jochen Walz, MD, about the reporting guidelines that SPARC outlines for nuclear medicine physicians.

This episode is sponsored by the European Association of Urology: https://uroweb.org